COMP <GO>
OBIO vs CGC // FORWARD P/E MULTIPLE
Orchestra BioMed Holdings Inc. (NASDAQ) VS. Canopy Growth Corporation (NASDAQ) • 15-METRIC TALLY: OBIO 3
— CGC 0
■ METRIC PARITY
LAST: $6.09 (+1.67%) • MKT CAP: $366.0M
forward-pe
—
LAST: $0.68 (+0.46%) • MKT CAP: $285.6M
forward-pe
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OBIO VS. CGC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | OBIO | CGC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 96.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -13.51% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 180.00% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 1/9 | +4.00 | OBIO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.6 | 24.9 | +28.75 | OBIO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $366.0M | $285.6M | $80.5M | OBIO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | OBIO REV | CGC REV | OBIO GROSS % | CGC GROSS % | OBIO FCF | CGC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $33.5M | $0 | 98.0% | — | -$49.5M | — |
| FY 2024 | $2.6M | $0 | 92.3% | — | -$50.8M | — |
| FY 2023 | $2.8M | $0 | — | — | -$46.1M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OBIO // BETA —
CGC // BETA —